Additional Information
Short Description: |
Topoisomerase I inhibitor |
Research Area: |
Cancer, Apoptosis |
Alternative Name(s): |
(4S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
Category: |
Small Molecules |
Product Type: |
Inhibitor |
CAS No.: |
7689-03-4 |
Molecular Formula: |
C20H16N2O4 |
Molecular Weight: |
348,36 |
Source: |
Synthetic |
Purity: |
>98% |
Solubility: |
Soluble to 5 mM in DMSO |
Appearance: |
Yellow solid |
Storage: |
-20ºC |
Shipping: |
Shipped Ambient |
SMILES: |
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O |
InChI: |
InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1 |
InChIKey: |
VSJKWCGYPAHWDS-FQEVSTJZSA-N |
Field of Use: |
For in vitro research use only. |
Related Products
Camptothecin (2 mg/ml) | 1039
26
NULL322.00
Reversibly inhibits nuclear topoisomerase I by binding to and stabilizing the topoisomerase-DNA covalent complex. Inhibits Tat-mediated transcription of HIV-1. Induces apoptosis in Jurkat,...
26-1039-GEN
Camptothecine | E1KS1288
426
NULL405.00
Camptothecine | E1KS1288 | Gentaur UK, US & Europe Distribution
426-E1KS1288
Jurkat cell Lysate (Camptothecin-treated) | 2402
26
NULL388.00
Jurkat cells were treated with 2 mM camptothecin for 6 hours. Cell lysate was prepared by homogenization in modified RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic...
26-2402-GEN
